Pine River Capital Management’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
Other funds holding SVA
SA
O
USAA
FIM
Pine River Capital Management's SVA Position: Q4 2016 in Review
Pine River Capital Management sold out of Sinovac Biotech, Ltd (SVA) in Q4 2016, closing a stake of 106,198 shares — an estimated $627K sold.
Pine River Capital Management first reported a position in SVA in Q2 2013 and held it in 13 quarters. The position peaked at $5.75M in Q2 2015. 38 funds tracked by Wall St. Rank hold SVA as of Q4 2016.
- Pine River Capital Management reported no remaining Sinovac Biotech, Ltd position as of Q4 2016 after selling out during the quarter.
- Pine River Capital Management sold 106,198 Sinovac Biotech, Ltd shares in Q4 2016, an estimated $627K.
- Pine River Capital Management first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 13 quarters.
- Pine River Capital Management's Sinovac Biotech, Ltd position peaked at $5.75M in Q2 2015.
- 38 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2016.
Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.